Skip to main content

Temperature

0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Effects of ClothingN/A1 trial
Active Trials
NCT01454882Completed39Est. Jan 2016
Masimo
MasimoIRVINE, CA
1 program
INVSENSOR00048N/A1 trial
Active Trials
NCT06922461Terminated4Est. May 2025
SPARK Biopharma
SPARK BiopharmaKorea - Seoul
1 program
TempTraqN/A1 trial
Active Trials
NCT03264833Completed60Est. Oct 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MasimoINVSENSOR00048
SPARK BiopharmaTempTraq
Colorado TherapeuticsEffects of Clothing

Clinical Trials (3)

Total enrollment: 103 patients across 3 trials

NCT06922461MasimoINVSENSOR00048

Clinical Performance of Masimo INVSENSOR00048 (DALI0001)

Start: May 2025Est. completion: May 20254 patients
N/ATerminated

Accuracy and Precision Comparison of Temptraq

Start: Dec 2016Est. completion: Oct 201760 patients
N/ACompleted

Measuring Free-living Energy Expenditure Using Direct Calorimetry

Start: Jan 2012Est. completion: Jan 201639 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.